Lipid management: Considerations in acute coronary syndrome

Authors

Venkateshwar R. Polsani, Baylor College of Medicine, United States
Salim S. Virani, Baylor College of Medicine, United StatesFollow
Vijay Nambi, Baylor College of Medicine, United States

Document Type

Article

Department

Cardiology

Abstract

Managing dyslipidemia is an important part of the primary and secondary prevention of coronary heart disease. Low-density lipoprotein cholesterol reduction remains the primary lipid goal. Patients who have experienced an acute coronary syndrome (ACS) are at very high risk of recurrent adverse cardiovascular events. A growing body of literature supports the concept that early and intensive treatment with statins after an ACS event decreases recurrent adverse cardiovascular events. We review available evidence pertaining to lipid alterations in ACS.

Comments

Abstract is not provided by the author/publisher. This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

Current Cardiology Reports

Recommended Citation

Polsani, V. R., Virani, S. S., Nambi, V. (2008). Lipid management: Considerations in acute coronary syndrome. Current Cardiology Reports, 10(4), 334-341.
Available at: https://ecommons.aku.edu/provost_office/293